Female Infertility Diagnosis and Treatment Market
Female Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Diagnosis (Ovulation Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others), by Treatment (Drugs, Surgery, Intrauterine Insemination (IUI), and Assisted Reproductive Technology (ART)), and by End-User (Hospitals and Clinics, Homecare, and Pathology and Diagnostic Centers) Forecast Period (2024-2031)
Female infertility diagnosis and treatment market is anticipated to grow at a CAGR of 5.6% during the forecast period (2024-2031). The female infertility diagnosis and treatment market is driven by factors such as high infertility prevalence, technological advancements, increasing awareness, supportive healthcare policies, and changing societal attitudes. Public health campaigns, educational initiatives, and advances in Assisted Reproductive Technologies (ART) have increased demand for early diagnosis and treatment. Government policies and insurance coverage also contribute to industry growth. Socioeconomic factors, such as rising disposable incomes and economic stability, additionally contributed to the demand for infertility diagnosis and treatment services. Lifestyle factors, such as delayed childbearing and lifestyle challenges, also drive demand for diagnostics and treatments. Polycystic Ovary Syndrome (PCOS) is a common cause of infertility, and its associated health issues make comprehensive management critical. Cultural and social acceptance, research and development initiatives, and global healthcare accessibility also contribute to the market's growth.
Market Dynamics
Prevalence of Polycystic Ovary Syndrome (PCOS)
Polycystic ovary syndrome (PCOS) influences women globally who possess age to reproduce, there has been an enormous demand for fertility treatments and diagnostic services to address the disorder's possibilities on fertility. According to the World Health Organization, in June 2023, approximately 8-13% of reproductive-aged women are estimated to be affected by polycystic ovary syndrome (PCOS), with up to 70% of affected women remaining undiagnosed worldwide. PCOS is a common cause of anovulation and infertility and is associated with various long-term health problems that impact physical and emotional well-being. It is worth noting that PCOS can be hereditary, but there are ethnic variations in its manifestations and effects, affecting roughly 116 million women globally (3.4% of the female population).
High Prevalence of Infertility
Increasing rates of infertility demand significant diagnostic and treatments, that emphasize the need for accessible fertility care at all income ranges. According to the World Health Organization, in April 2023, infertility affects 17.5% of the adult population, affecting 1 in 6 globally. The prevalence is comparable across high-, middle-, and low-income countries. Fertility treatment is often uninsured, leaving patients paying upwards of $10,000, making it a significant global health issue.
Market Segmentation
- Based on material type, the market is segmented into Ovulation Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others (Laparoscopy).
- Based on treatment, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART).
- Based on the end-user, the market is segmented into hospitals and clinics, home care, and pathology and diagnostic centers.
Assisted Reproductive Technology (ART) Sub-segment to Hold a Considerable Market Share
Fertility treatment success rates have been significantly improved by assisted reproductive technologies (ART). According to the US Department of Health and Human Services, in March 2024, millions of Americans suffered from infertility, which can be spurred on by age, health issues, or same-sex relationships. In vitro fertilization (IVF) and assisted reproductive technology (ART) are two fertility therapies that enable infertile individuals to grow their families. Utilizing ART, 86,146 infants had been produced in 2021. Moreover, IVF enables individuals to preserve their sperm, eggs, or reproductive organs for use in future generations.
Regional Outlook
The female infertility diagnosis and treatment market is further segmented based on geography including Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), North America (the US, and Canada), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Female Infertility Diagnosis and Treatment Market Growth by Region 2024-2031
North America Holds Major Market Share
Research and development initiatives are enhancing fertility care through innovative treatments and personalized medicine, allowing for tailored treatment plans based on specific diagnostic findings. For instance, in March 2024, Alife Health partnered with Boston IVF to pilot the country's first AI tool for IVF medication optimization. The software, called Stim Assist, helped clinicians retrieve optimal eggs and reduce medication costs. The partnership aims to improve reproductive medicine by combining Alife's AI technology with Boston IVF's expertise, enhancing treatment protocols, and improving success rates for couples.?
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the female infertility diagnosis and treatment market include AbbVie Inc., Bayer AG, CooperSurgical Inc., Eli Lilly and Co., and Merck KGaA, among others. Market expansion and applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in January 2022, Bitcoin-based tracking platform Eggschain partnered with Boston IVF to use blockchain technology for tracking cryogenically preserved sperm for in vitro fertilization and other fertility treatments. The partnership aims to increase transparency, verify data, and store sensitive genetic information while reducing time in the sperm selection process and preventing misfiling.
The Report Covers-
- Market value data analysis of 2023 and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global female infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Industry Trends
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Merck KGaA
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.2.5. Overview
3.2.6. Financial Analysis
3.2.7. SWOT Analysis
3.2.8. Recent Developments
3.3. Bayer AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. CooperSurgical, Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Female Infertility Market by Diagnosis
4.1.1. Ovulation Testing
4.1.2. Hysterosalpingography (HSG)
4.1.3. Hysteroscopy
4.1.4. Imaging Testing
4.1.5. Ovarian Reserve Testing
4.1.6. Hormonal Level Testing
4.1.7. Genetic Testing
4.1.8. Others (Laparoscopy)
4.2. Global Female Infertility Market by Treatment
4.2.1. Drugs
4.2.2. Surgery
4.2.3. Intrauterine Insemination (IUI)
4.2.4. Assisted Reproductive Technology (ART)
4.3. Global Female Infertility Diagnosis and Treatment Market by End-User
4.3.1. Hospitals and Clinics
4.3.2. Homecare
4.3.3. Pathology and Diagnostic Centers
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East and Africa
6. Company Profiles
6.1. AbbVie, Inc.
6.2. Cook Group Inc.
6.3. ESCO Group
6.4. Fairhaven Health
6.5. Ferring B.V.
6.6. Fresenius Kabi AG
6.7. FUJIFILM Irvine Scientific, Inc.
6.8. Gedeon Richter Plc.
6.9. GlaxoSmithKline plc
6.10. Hamilton Thorne Inc.
6.11. INVO Bioscience
6.12. IVFtech ApS
6.13. Laboratory Corporation of America Holdings
6.14. LG Chem
6.15. Myovant Sciences
6.16. OBG Pharmaceuticals Ltd.
6.17. Pfizer, Inc.
6.18. Princeton BioMeditech Corp.
6.19. Rocket Medical plc.
6.20. Thermo Fisher Scientific Inc.
1. Global Female Infertility Market Research And Analysis By Diagnosis, 2023-2031 ($ Million)
2. Global Ovulation Testing Market Research And Analysis By Region, 2023-2031 ($ Million)
3. Global Hysterosalpingography Market Research And Analysis By Region, 2023-2031 ($ Million)
4. Global Hysteroscopy Market Research And Analysis By Region, 2023-2031 ($ Million)
5. Global Imaging Testing For Female Infertility Diagnosis Market Research And Analysis By Region, 2023-2031 ($ Million)
6. Global Ovarian Reserve Testing Market Research And Analysis By Region, 2023-2031 ($ Million)
7. Global Hormonal Level Testing Market Research And Analysis By Region, 2023-2031 ($ Million)
8. Global Genetic Testing For Female Infertility Diagnosis Market Research And Analysis By Region, 2023-2031 ($ Million)
9. Global Other Female Infertility Diagnosis Market Research And Analysis By Region, 2023-2031 ($ Million)
10. Global Female Infertility Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
11. Global Female Infertility Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
12. Global Female Infertility Surgery Market Research And Analysis By Region, 2023-2031 ($ Million)
13. Global Intrauterine Insemination For Female Infertility Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
14. Global Assisted Reproductive Technology For Female Infertility Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
15. Global Female Infertility Diagnosis And Treatment Market Research And Analysis By End-User, 2023-2031 ($ Million)
16. Global Female Infertility Diagnosis And Treatment In Hospitals And Clinics Market Research And Analysis By Region, 2023-2031 ($ Million)
17. Global Female Infertility Diagnosis And Treatment In Homecare Market Research And Analysis By Region, 2023-2031 ($ Million)
18. Global Female Infertility Diagnosis And Treatment In Pathology And Diagnostic Centers Market Research And Analysis By Region, 2023-2031 ($ Million)
19. Global Polycystic Ovarian Syndrome Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
20. Global Female Infertility Diagnosis And Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
21. North American Female Infertility Diagnosis And Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
22. North American Female Infertility Market Research And Analysis By Diagnosis, 2023-2031 ($ Million)
23. North American Female Infertility Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
24. North American Female Infertility Diagnosis And Treatment Market Research And Analysis By End-User, 2023-2031 ($ Million)
25. European Female Infertility Diagnosis And Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
26. European Female Infertility Market Research And Analysis By Diagnosis, 2023-2031 ($ Million)
27. European Female Infertility Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
28. European Female Infertility Diagnosis And Treatment Market Research And Analysis By End-User, 2023-2031 ($ Million)
29. Asia-Pacific Female Infertility Diagnosis And Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
30. Asia-Pacific Female Infertility Market Research And Analysis By Diagnosis, 2023-2031 ($ Million)
31. Asia-Pacific Female Infertility Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
32. Asia-Pacific Female Infertility Diagnosis And Treatment Market Research And Analysis By End-User, 2023-2031 ($ Million)
33. Rest Of The World Female Infertility Diagnosis And Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
34. Rest Of The World Female Infertility Market Research And Analysis By Diagnosis, 2023-2031 ($ Million)
35. Rest Of The World Female Infertility Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
36. Rest Of The World Female Infertility Diagnosis And Treatment Market Research And Analysis By End-User, 2023-2031 ($ Million)
1. Global Female Infertility Market Share By Diagnosis, 2023 Vs 2031 (%)
2. Global Ovulation Testing Market Share By Region, 2023 Vs 2031 (%)
3. Global Hysterosalpingography Market Share By Region, 2023 Vs 2031 (%)
4. Global Hysteroscopy Market Share By Region, 2023 Vs 2031 (%)
5. Global Imaging Testing For Female Infertility Diagnosis Market Share By Region, 2023 Vs 2031 (%)
6. Global Ovarian Reserve Testing Market Share By Region, 2023 Vs 2031 (%)
7. Global Hormonal Level Testing Market Share By Region, 2023 Vs 2031 (%)
8. Global Genetic Testing For Female Infertility Diagnosis Market Share By Region, 2023 Vs 2031 (%)
9. Global Other Female Infertility Diagnosis Market Share By Region, 2023 Vs 2031 (%)
10. Global Female Infertility Market Share Analysis By Treatment Type, 2023 Vs 2031 (%)
11. Global Female Infertility Drug Market Share By Region, 2023 Vs 2031 (%)
12. Global Female Infertility Surgery Market Share By Region, 2023 Vs 2031 (%)
13. Global Intrauterine Insemination For Female Infertility Treatment Market Share By Region, 2023 Vs 2031 (%)
14. Global Assisted Reproductive Technology For Female Infertility Treatment Market Share By Region, 2023 Vs 2031 (%)
15. Global Female Infertility Diagnosis And Treatment Market Share By End-User, 2023 Vs 2031 (%)
16. Global Female Infertility Diagnosis And Treatment In Hospitals And Clinics Market Share By Region, 2023 Vs 2031 (%)
17. Global Female Infertility Diagnosis And Treatment In Homecare Market Share By Region, 2023 Vs 2031 (%)
18. Global Female Infertility Diagnosis And Treatment In Pathology And Diagnostic Centers Market Share By Region, 2023 Vs 2031 (%)
19. Global Endometriosis Drug Market Share By Region, 2023 Vs 2031 (%)
20. Global Polycystic Ovarian Syndrome Drug Market Share By Region, 2023 Vs 2031 (%)
21. Global Female Infertility Diagnosis And Treatment Market Share By Region, 2023 Vs 2031 (%)
22. US Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
23. Canada Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
24. UK Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
25. France Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
26. Germany Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
27. Italy Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
28. Spain Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
29. Rest Of Europe Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
30. India Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
31. China Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
32. Japan Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
33. South Korea Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
34. Rest Of Asia-Pacific Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
35. Latin America Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
36. Middle East And Africa Female Infertility Diagnosis And Treatment Market Size, 2023-2031 ($ Million)
